Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases

Author(s):  Mixon William, Helms Scott R

Issue:  Sep/Oct 2008 - Veterinary Compounding
View All Articles in Issue

Page(s):  392-397

Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Page 1
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Page 2
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Page 3
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Page 4
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Page 5
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Page 6

Download in electronic PDF format for $65

Abstract:  Primary hypertension may be more common in cats than prior research has indicated. Untreated feline hypertension damages organs nourished by a rich vascular supply, and kidney disease, ocular impairment, and cardiac irregularities can be caused by this silent and progressive disorder. The effects of hypertension can be minimized with treatment, however, and the long-acting dihydropyridine calcium antagonist amlodipine has been proven safe and effective in the management of high blood pressure in cats. Because anxiety can increase blood pressure even in normotensive cats, hypertensive feline patients must be protected as much as possible from the stress caused by forced medication. A compounded preparation of amlodipine in a transdermal gel can be easily applied to the feline pinna without subjecting the patient to the trauma of oral treatment. In this report, the potency and effectiveness of amlodipine besylate in Lipoderm transdermal gel for the treatment of feline hypertension are examined, and two case rep

Related Keywords: William Mixon, RPh, MS, FIACP, Scott R. Helms, DVM, Diplomate ABVP, feline primary hypertension, cats, high blood pressure, cardiovascular disorders, case reports, amlodipine besylate, antihypertensive agent, Lipoderm gel, transdermal administration, topical preparation, potency, veterinary medicine

Related Categories: VETERINARY, CASE REPORTS, CARDIOLOGY, DOSAGE FORMS/DRUG CARRIERS, LITERATURE REVIEW

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William
, Helms Scott R
Sep/Oct 2008
Pg. 392-397

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Rudner Shara
, Browne Paul
Nov/Dec 2010
Pg. 488-491

Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R
, Fox Samantha, Mixon William, Vail Jane
Jan/Feb 2012
Pg. 34-41

Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig
, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022
Pg. 468-472

Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William
, Angelle Patricea, Yoch Douglas
Jan/Feb 2009
Pg. 6-12

Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt
Graves Richard A
, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V
Nov/Dec 2019
Pg. 519-527

Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Fields Shannon W
Nov/Dec 2006
Pg. 418

Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Davidson Michael G
Mar/Apr 2001
Pg. 92-94

Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 43

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions